CSPG4 and neoplasm: However, since in several malignancies tumor cells have been reported to escape T-cell recognition [93, 94], more and more researchers have focused their attentions on mAb-based therapies and several studies have investigated the potentiality of mAb-based anti-tumor strategies directed against CSPG4.